Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

ipation in API for our shareholders," said Dr. William Hunter, President and Chief Executive Officer of Angiotech. "We are excited to work with our new partners at Ares and New Leaf, who offer us considerable capital resources and business experience, to execute our strategy of developing drug-device combinations, locally deliverable drugs, or other novel technologies that improve the outcomes of surgical or other medical interventions."

"This transaction offers Angiotech the opportunity for meaningful reduction of debt and interest expense, and allows us to raise a total amount of proceeds greater than would have been reasonably achievable through the consolidated company's capital alternatives," said Thomas Bailey, Chief Financial Officer of Angiotech. "After considering a wide range of strategic alternatives with the assistance of our advisors, our Board determined that this transaction establishes a more flexible capital structure to support our various business and product development initiatives."

"We are pleased, together with New Leaf, to have the opportunity to work with Angiotech to establish and capitalize API," said Bennett Rosenthal, Senior Partner of Ares Management. "The combination of our firms' significant capital resources, financial expertise and health care investing experience make us ideal partners for API. We are all tremendously excited about the market potential and growth trajectory of the company's various product opportunities."

"New Leaf and Ares believe that Angiotech has a very attractive portfolio of marketed products and pipeline programs, and that this transaction puts the Company in the best position to support these assets with the investments needed to maximize their long term potential," said Ron Hunt, Managing Director of New Leaf Venture Partners, LLC.

Transaction Highlights

- Raises substantial proceeds in equity-linked security targeted to

reduce cash pay debt. The propos
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... device," Nobel laureate Herbert Kroemer famously observed, ... found at the junctures where layers of ... of nanotechnology, the interfaces between layers of ... applications in such high-tech favorites as spintronics, ... vast potential of these metal oxide interfaces, ...
(Date:1/15/2014)... Jan. 15, 2014   Niagara Thermal Products ... been selected by Buffalo BioBlower Technologies LLC ("B3") ... of its SBIR Phase 2 award from the ... only comprehensive air purification system that kills all ... pollutants, allergens and organic particulates.  In independent testing ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... company developing antibody-drug conjugates for cancer, today announced the ... Board of Directors. Dr Reynolds has over 20 years, ... as Chief Medical Officer at Seattle Genetics. ... time for Oxford BioTherapeutics, as the company completes its ...
(Date:1/15/2014)... -- A study has been launched to ... Formula 1 track could help to tackle the problem ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... by healthcare provider Simplyhealth. Telemetry technology, which ... the on-track performance of Vodafone McLaren Mercedes Formula 1 ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... Dmitriy Ovcharenko, Rich Jarvis, , ... , ... experimental tool for reducing the expression of specific , ... gene function analysis, target , ...
... Ambion's newest line of plasmid siRNA , ... feature polymerase (pol) II promoters that drive transcription , ... an antibiotic resistance gene. , The ... strong promoter is active in a broad range of cell types and , ...
... Trace amounts of ribonuclease (RNase) , ... RNases are , ubiquitous in ... air, on anything touched by bare hands or on anything left , ... , or eliminate RNase contamination. ...
Cached Biology Technology:Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7Drive Long-Term Silencing with CMV Vectors 2Drive Long-Term Silencing with CMV Vectors 3Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5
(Date:4/16/2014)... memories improves during childhood, associated with structural changes ... and parietal cortices. New research from UC Davis ... this crucial time. Eventually, that could give insights ... into and during adolescence and affect memory, such ... the middle of the brain, the hippocampus plays ...
(Date:4/16/2014)... composed of Dr. Martin Prechtl, Leo Heim and their ... has discovered a new method of generating hydrogen using ... is of particular interest when it comes to fuel ... and mild hydrogen production using water and formaldehyde", have ... . , Among other applications, the new approach can ...
(Date:4/15/2014)... away in Hartford, Connecticut, a Puerto Rican community is ... that is so authentic it has caught the attention ... Gregory J. Anderson (University of Connecticut) took a close ... markets of Hartford and uncovered evidence that gives new ... using for years: home is in the kitchen. , ...
Breaking Biology News(10 mins):How kids' brain structures grow as memory develops 2The human food connection: A new study reveals more about our relationship to food 2The human food connection: A new study reveals more about our relationship to food 3
... Spanish . , How can it be proved ... have a cognitive problem, such as memory or concentration problems ... and even feign them in order to receive more money ... a pioneering research in Spain. This research was carried out ...
... YORK, Jan. 10 U.S. Market for Personal Safes, a ... for,personal safes will grow by double digits in 2008 and ... personal safes accounted for 36%,of the overall U.S. safes market. ... share. An estimated 300,000 safes are sold each year in,the ...
... Harbor Laboratorys (CSHL) researcher Raffaella Sordella, Ph.D. was awarded ... Conquer Lung Cancer. The two-year grant will fund CSHLs ... genetic mutations that appear to be a trigger in ... deaths in the United States. The mutations, called ...
Cached Biology News:Half of the people suffering from head injuries fake to receive financial help 2Personal Safes Market to Top $308 Million by 2011 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
Imject Freund's Complete Adjuvant (FCA)...
... cytoplasmic granules, is a key step ... (e.g. basophils, neutrophils, eosinophils, and mast ... secretory granules contain many proinflammatory mediators ... proteases (Hallgren, 2001). Tryptase, a tetrameric ...
... was developed specifically for reduced mutagenicity to ... in agarose or acrylamide gels. SYBR Safe stain ... but SYBR Safe stain's detection sensitivity is better ... comes as a premixed solution that can be ...
... The S&S Custom Processing Service enables scientists who ... and data analysis software to have their biological ... 16 analytes. Its as easy as 1-2-3 ... quantified in your samples from the S&S antibody ...
Biology Products: